
    
      This prospective, non-comparative, single-center, post-market trial will evaluate the safety
      and efficacy of the PEEK-OPTIMA â„¢ HA Enhanced Keos Lumbar Interbody Fusion Device in patients
      suffering from degenerative disc disease, spondylolisthesis and retrolisthesis in the lumbar
      spine. The trial will capture clinical outcomes, radiographic and CT outcomes over a 24 month
      period post operatively. One centre will be involved in the recruitment of 30 patients the
      clinic involved will focus on this type of treatment.
    
  